Optimizing performance and interpretation of prostate biopsy: A critical analysis of the literature

European Urology

Volumn 58, Issue 6, 2010, Pages 851-864

  Chun, Felix K H ^a   Epstein, Jonathan I ^b   Ficarra, Vincenzo ^c   Freedland, Stephen J ^d   Montironi, Rodolfo ^e   Montorsi, Francesco ^f   Shariat, Shahrokh F ^g   Schröder, Fritz H ^h   Scattoni, Vincenzo ^f  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Optimal sampling; Prostate biopsy; Prostate cancer detection; Review

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BIOPSY TECHNIQUE; CANCER DIAGNOSIS; CANCER GRADING; CELL PROLIFERATION; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; HUMAN; NOMOGRAM; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SATURATION BIOPSY; SCORING SYSTEM; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY, NEEDLE; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 78049471852     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.08.041     Document Type: Review

References (128)

1. F.H. Schroder, J. Hugosson, and M.J. Roobol Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
2. G.L. Andriole, E.D. Crawford, and R.L. Grubb III Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310 1319
3. J. Noldus, M. Graefen, A. Haese, R.P. Henke, P. Hammerer, and H. Huland Stage migration in clinically localized prostate cancer Eur Urol 38 2000 74 78
4. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534 (Pubitemid 43898816)
5. A. Gallina, F.K. Chun, and N. Suardi Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer BJU Int 101 2008 1513 1518
6. A. Heidenreich, G. Aus, and M. Bolla EAU guidelines on prostate cancer Eur Urol 53 2008 68 80
7. A. Haese, A. de la Taille, and H. van Poppel Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy Eur Urol 54 2008 1081 1088
8. F.K. Chun, A. de la Taille, and H. van Poppel Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram Eur Urol 56 2009 659 668
9. I.L. Deras, S.M. Aubin, and A. Blase PCA3: a molecular urine assay for predicting prostate biopsy outcome J Urol 179 2008 1587 1592
10. J. Groskopf, S.M. Aubin, and I.L. Deras APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer Clin Chem 52 2006 1089 1095
11. L.S. Marks, and D.G. Bostwick Prostate cancer specificity of PCA3 gene testing: examples from clinical practice Rev Urol 10 2008 175 181
12. L.S. Marks, Y. Fradet, and I.L. Deras PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy Urology 69 2007 532 535
13. F.K.-H. Chun, A. Briganti, and M. Graefen Development and external validation of an extended 10-core biopsy nomogram Eur Urol 52 2007 436 445 (Pubitemid 46963425)
14. V. Scattoni, A. Zlotta, R. Montironi, C. Schulman, P. Rigatti, and F. Montorsi Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature Eur Urol 52 2007 1309 1322
15. R.S. Punglia, A.V. D'Amico, W.J. Catalona, K.A. Roehl, and K.M. Kuntz Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen N Engl J Med 349 2003 335 342
16. A.S. Elstein Heuristics and biases: selected errors in clinical reasoning Acad Med 74 1999 791 794
17. I. Vlaev, and N. Chater Game relativity: how context influences strategic decision making J Exp Psychol 32 2006 131 149
18. M. Kattan Expert systems in medicine N.J. Smelser, P.B. Baltes, International Encyclopedia of the Social and Behavioral Sciences 2001 Pergamon Oxford, UK 5135 5139
19. R.M. Hogarth, and N. Karelaia Heuristic and linear models of judgment: matching rules and environments Psychol Rev 114 2007 733 758
20. P.L. Ross, C. Gerigk, and M. Gonen Comparisons of nomograms and urologists' predictions in prostate cancer Semin Urol Oncol 20 2002 82 88
21. M.C. Specht, M.W. Kattan, M. Gonen, J. Fey, and K.J. Van Zee Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram Ann Surg Oncol 12 2005 654 659
22. J. Walz, A. Gallina, and P. Perrotte Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer BJU Int 100 2007 1254 1258
23. F.K.-H. Chun, P.I. Karakiewicz, and A. Briganti Prostate cancer nomograms: an update Eur Urol 50 2006 914 926 discussion 926
24. S. Kawakami, N. Numao, and Y. Okubo Development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy Eur Urol 54 2008 601 611
25. F. Chun, A. Briganti, and M. Graefen Development and external validation of an extended repeat biopsy nomogram J Urol 177 2007 510 515 (Pubitemid 46054043)
26. F.K.-H. Chun, M. Graefen, and A. Briganti Initial biopsy outcome prediction - head-to-head comparison of a logistic regression-based nomogram versus artificial neural network Eur Urol 51 2007 1236 1243 discussion 1241-3
27. A.J. Stephenson, A. Smith, and M.W. Kattan Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy Cancer 104 2005 290 298
28. M.R. Cooperberg, D.P. Lubeck, M.V. Meng, S.S. Mehta, and P.R. Carroll The changing face of low-risk prostate cancer: trends in clinical presentation and primary management J Clin Oncol 22 2004 2141 2149
29. J.S. Jones Prostate cancer: are we over-diagnosing - or under-thinking? Eur Urol 53 2008 10 12
30. M.W. Kattan, and J.S. Jones The ultimate prostate cancer biopsy decision support tool Eur Urol 57 2010 9 10 discussion 10-1
31. H. Ide, M. Yasuda, and K. Nishio Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels Anticancer Res 28 2008 2487 2492
32. R.K. Nam, A. Toi, and L.H. Klotz Assessing individual risk for prostate cancer J Clin Oncol 25 2007 3582 3588
33. P.C. Albertsen, J.A. Hanley, D.F. Gleason, and M.J. Barry Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer JAMA 280 1998 975 980
34. R.G. Uzzo, J.T. Wei, R.S. Waldbaum, A.P. Perlmutter, J.C. Byrne, and E.D. Vaughan Jr. The influence of prostate size on cancer detection Urology 46 1995 831 836
35. F.K.-H. Chun, A. Briganti, and M. Graefen Development and external validation of an extended 10-core biopsy nomogram Eur Urol 52 2007 436 445 (Pubitemid 46963425)
36. F.K. Chun, A. Briganti, and M. Graefen Development and external validation of an extended repeat biopsy nomogram J Urol 177 2007 510 515 (Pubitemid 46054043)
37. S.J. Freedland, W.B. Isaacs, and E.A. Platz Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study J Clin Oncol 23 2005 7546 7554
38. A. Briganti, F.K. Chun, and N. Suardi Prostate volume and adverse prostate cancer features: fact not artifact Eur J Cancer 43 2007 2669 2677
39. K.K. Hodge, J.E. McNeal, M.K. Terris, and T.A. Stamey Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate J Urol 142 1989 71 74 discussion 74-5
40. A.P. Berger, C. Gozzi, and H. Steiner Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores J Urol 171 2004 1478 1480 discussion 1480-1
41. W. Siu, R.L. Dunn, R.B. Shah, and J.T. Wei Use of extended pattern technique for initial prostate biopsy J Urol 174 2005 505 509
42. L.A. Eskew, R.L. Bare, and D.L. McCullough Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 157 1997 199 202 discussion 202-3
43. J.C.J. Presti, J.J. Chang, V. Bhargava, and K. Shinohara The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial J Urol 163 2000 163 166 discussion 166-7
44. J.L. Gore, S.F. Shariat, and B.J. Miles Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer J Urol 165 2001 1554 1559
45. G. Guichard, S. Larré, and A. Gallina Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients Eur Urol 52 2007 430 435
46. V. Ravery, S. Dominique, X. Panhard, M. Toublanc, L. Boccon-Gibod, and L. Boccon-Gibod The 20-core prostate biopsy protocol - a new gold standard? J Urol 179 2008 504 507
47. G.P. Haas, N.B. Delongchamps, and R.F. Jones Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence J Natl Cancer Inst 99 2007 1484 1489
48. V. Scattoni, M. Roscigno, and M. Raber Initial extended transrectal prostate biopsy - are more prostate cancers detected with 18 cores than with 12 cores? J Urol 179 2008 1327 1331 discussion 1331
49. V. Scattoni, M. Raber, and F. Abdollah Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy Eur Urol 57 2010 1 8
50. K. Eichler, S. Hempel, J. Wilby, L. Myers, L.M. Bachmann, and J. Kleijnen Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review J Urol 175 2006 1605 1612
51. A. de la Taille, P. Antiphon, and L. Salomon Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate Urology 61 2003 1181 1186
52. V. Ficarra, G. Novella, and G. Novara The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy Eur Urol 48 2005 932 937
53. M. Inahara, H. Suzuki, and S. Kojima Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings Urology 68 2006 815 819
54. V. Ravery, L. Goldblatt, B. Royer, E. Blanc, M. Toublanc, and L. Boccon-Gibod Extensive biopsy protocol improves the detection rate of prostate cancer J Urol 164 2000 393 396
55. T.A. Stamey Making the most out of six systematic sextant biopsies Urology 45 1995 2 12
56. M. Remzi, Y.K. Fong, and M. Dobrovits The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume J Urol 174 2005 1256 1260 discussion 1260-1; author reply 1261
57. J. Jiang, J. Colli, and R. El-Galley A simple method for estimating the optimum number of prostate biopsy cores needed to maintain high cancer detection rates while minimizing unnecessary biopsy sampling J Endourol 24 2010 143 147
58. H. Singh, E.I. Canto, and S.F. Shariat Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy J Urol 171 2004 204 209
59. J.C. Presti Jr., G.J. O'Dowd, M.C. Miller, R. Mattu, and R.W. Veltri Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study J Urol 169 2003 125 129
60. J.E. McNeal, E.A. Redwine, F.S. Freiha, and T.A. Stamey Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread Am J Surg Pathol 12 1988 897 906
61. R. Takashima, S. Egawa, S. Kuwao, and S. Baba Anterior distribution of stage T1c nonpalpable tumors in radical prostatectomy specimens Urology 59 2002 692 697
62. A.R. Patel, J.S. Jones, J. Rabets, G. DeOreo, and C.D. Zippe Parasagittal biopsies add minimal information in repeat saturation prostate biopsy Urology 63 2004 87 89
63. National Comprehensive Cancer Network. National Comprehensive, 2004. http://www.nccn.org/professionals/physician-gls/PDF/prostate-detection.pdf.
64. J.C. Applewhite, B.R. Matlaga, and D.L. McCullough Results of the 5 region prostate biopsy method: the repeat biopsy population J Urol 168 2002 500 503
65. B. Djavan, V. Ravery, and A. Zlotta Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop? J Urol 166 2001 1679 1683
66. C.G. Roehrborn, G.J. Pickens, and J.S. Sanders Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels Urology 47 1996 347 352
67. D.W. Keetch, W.J. Catalona, and D.S. Smith Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values J Urol 151 1994 1571 1574
68. N.E. Fleshner, M. O'Sullivan, and W.R. Fair Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate J Urol 158 1997 505 508 discussion 508-9
69. J.B. Rietbergen, A.E. Kruger, R.F. Hoedemaeker, C.H. Bangma, W.J. Kirkels, and F.H. Schroder Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: clinical and pathological features of detected cancer J Urol 160 1998 2121 2125
70. J.L. Letran, A.B. Blase, F.R. Loberiza, G.E. Meyer, S.D. Ransom, and M.K. Brawer Repeat ultrasound guided prostate needle biopsy: use of free-to-total prostate specific antigen ratio in predicting prostatic carcinoma J Urol 160 1998 426 429
71. P.G. Borboroglu, S.W. Comer, R.H. Riffenburgh, and C.L. Amling Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies J Urol 163 2000 158 162
72. B. Djavan, A. Zlotta, and M. Remzi Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men J Urol 163 2000 1144 1148 discussion 1148-9
73. G.J. O'dowd, M.C. Miller, R. Orozco, and R.W. Veltri Analysis of repeated biopsy results within 1 year after a noncancer diagnosis Urology 55 2000 553 559
74. C.S. Stewart, B.C. Leibovich, A.L. Weaver, and M.M. Lieber Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies J Urol 166 2001 86 91 discussion 91-2
75. Y.M. Hong, F.C. Lai, C.H. Chon, J.E. McNeal, and J.C. Presti Jr. Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies Urol Oncol 22 2004 7 10
76. H. Singh, E.I. Canto, and S.F. Shariat Predictors of prostate cancer after initial negative systematic 12 core biopsy J Urol 171 2004 1850 1854
77. J.L. Campos-Fernandes, L. Bastien, and N. Nicolaiew Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy Eur Urol 55 2009 600 609
78. V. Scattoni Systematic prostate biopsies are more and more often becoming saturation biopsies Eur Urol 50 2006 202 204
79. A.E. Pelzer, J. Bektic, and A.P. Berger Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the Tyrol screening project Eur Urol 48 2005 916 921 discussion 921
80. S.R. Bott, M.P. Young, M.J. Kellett, and M.C. Parkinson Anterior prostate cancer: is it more difficult to diagnose? BJU Int 89 2002 886 889
81. J.L. Wright, and W.J. Ellis Improved prostate cancer detection with anterior apical prostate biopsies Urol Oncol 24 2006 492 495
82. J.I. Epstein, and M. Herawi Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care J Urol 175 2006 820 834
83. D.G. Bostwick, and R. Montironi Prostatic intraepithelial neoplasia and the origins of prostatic carcinoma Pathol Res Pract 191 1995 828 832
84. N. Gokden, K.A. Roehl, W.J. Catalona, and P.A. Humphrey High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population Urology 65 2005 538 542
85. T. Bishara, D.M. Ramnani, and J.I. Epstein High-grade prostatic intraepithelial neoplasia on needle biopsy: risk of cancer on repeat biopsy related to number of involved cores and morphologic pattern Am J Surg Pathol 28 2004 629 633
86. F. Gallo, L. Chiono, E. Gastaldi, E. Venturino, and C. Giberti Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies Urology 72 2008 628 632
87. L. Benecchi, A.M. Pieri, M. Melissari, M. Potenzoni, and C.D. Pastizzaro A novel nomogram to predict the probability of prostate cancer on repeat biopsy J Urol 180 2008 146 149
88. M.A. Rochester, N. Pashayan, F. Matthews, A. Doble, and J. McLoughlin Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population BMC Urol 9 2009 7
89. R. Simon, and D.G. Altman Statistical aspects of prognostic factor studies in oncology Br J Cancer 69 1994 979 985
90. G.J. Netto, and J.I. Epstein Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma Am J Surg Pathol 30 2006 1184 1188
91. M. Roscigno, V. Scattoni, and M. Freschi Monofocal and plurifocal high-grade prostatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy Urology 63 2004 1105 1110
92. C. De Nunzio, A. Trucchi, and R. Miano The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy J Urol 181 2009 1069 1074 discussion 1074-5
93. J.L. Merrimen, G. Jones, D. Walker, C.S. Leung, L.R. Kapusta, and J.R. Srigley Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma J Urol 182 2009 485 490 discussion 490
94. L. Schoenfield, J.S. Jones, and C.D. Zippe The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer BJU Int 99 2007 770 774
95. J.I. Epstein Precursor lesions to prostatic adenocarcinoma Virchows Arch 454 2009 1 16
96. R. Montironi, V. Scattoni, R. Mazzucchelli, A. Lopez-Beltran, D.G. Bostwick, and F. Montorsi Atypical foci suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") Eur Urol 50 2006 666 674
97. C. Gupta, J.Z. Ren, and K.J. Wojno Individual submission and embedding of prostate biopsies decreases rates of equivocal pathology reports Urology 63 2004 83 86
98. R. Abouassaly, N. Tan, A. Moussa, and J.S. Jones Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies J Urol 180 2008 911 914 discussion 914
99. T.Y. Chan, and J.I. Epstein Follow-up of atypical prostate needle biopsies suspicious for cancer Urology 53 1999 351 355
100. K.A. Iczkowski, T.J. Bassler, and V.S. Schwob Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer Urology 51 1998 749 757 discussion 757-8
101. E.A. Allen, H. Kahane, and J.I. Epstein Repeat biopsy strategies for men with atypical diagnoses on initial prostate needle biopsy Urology 52 1998 803 807
102. A.R. Patel, and J.S. Jones Optimal biopsy strategies for the diagnosis and staging of prostate cancer Curr Opin Urol 19 2009 232 237
103. J.C. Rabets, J.S. Jones, A. Patel, and C.D. Zippe Prostate cancer detection with office based saturation biopsy in a repeat biopsy population J Urol 172 2004 94 97
104. K.L. Chrouser, and M.M. Lieber Extended and saturation needle biopsy for the diagnosis of prostate cancer Curr Urol Rep 5 2004 226 230
105. R. Abouassaly, B.R. Lane, and J.S. Jones Staging saturation biopsy in patients with prostate cancer on active surveillance protocol Urology 71 2008 573 577
106. J.S. Jones, A. Patel, L. Schoenfield, J.C. Rabets, C.D. Zippe, and C. Magi-Galluzzi Saturation technique does not improve cancer detection as an initial prostate biopsy strategy J Urol 175 2006 485 488
107. B.R. Lane, C.D. Zippe, R. Abouassaly, L. Schoenfield, C. Magi-Galluzzi, and J.S. Jones Saturation technique does not decrease cancer detection during followup after initial prostate biopsy J Urol 179 2008 1746 1750 discussion 1750
108. K.A. Roehl, J.A. Antenor, and W.J. Catalona Serial biopsy results in prostate cancer screening study J Urol 167 2002 2435 2439
109. P. Pepe, and F. Aragona Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation Urology 70 2007 1131 1135
110. J.S. Jones Saturation biopsy for detecting and characterizing prostate cancer BJU Int 99 2007 1340 1344
111. J.I. Epstein, H. Sanderson, H.B. Carter, and D.O. Scharfstein Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy Urology 66 2005 356 360
112. S. Kawakami, T. Okuno, and J. Yonese Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy Eur Urol 51 2007 675 682 discussion 682-3
113. P. Emiliozzi, S. Longhi, P. Scarpone, A. Pansadoro, F. DePaula, and V. Pansadoro The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen J Urol 166 2001 845 850
114. T.C. Igel, M.K. Knight, and P.R. Young Systematic transperineal ultrasound guided template biopsy of the prostate in patients at high risk J Urol 165 2001 1575 1579
115. G.S. Merrick, S. Gutman, and H. Andreini Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy Eur Urol 52 2007 715 723
116. V. Ficarra, G. Martignoni, and G. Novella Needle core length is a quality indicator of systematic transperineal prostate biopsy Eur Urol 50 2006 266 271
117. L. Boccon-Gibod, T.H. van der Kwast, R. Montironi, L. Boccon-Gibod, and A. Bono Handling and pathology reporting of prostate biopsies Eur Urol 46 2004 177 181 (Pubitemid 38902732)
118. T.H. van der Kwast, C. Lopes, and C. Santonja Guidelines for processing and reporting of prostatic needle biopsies J Clin Pathol 56 2003 336 340
119. M.K. Terris, P.G. Hammerer, and M.E. Nickas Comparison of ultrasound imaging in patients undergoing transperineal and transrectal prostate ultrasound Urology 52 1998 1070 1072
120. R. Shinghal, and M.K. Terris Limitations of transperineal ultrasound-guided prostate biopsies Urology 54 1999 706 708
121. R. Hara, Y. Jo, and T. Fujii Optimal approach for prostate cancer detection as initial biopsy: prospective randomized study comparing transperineal versus transrectal systematic 12-core biopsy Urology 71 2008 191 195
122. A. Takenaka, R. Hara, and T. Ishimura A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy Prostate Cancer Prostatic Dis 11 2008 134 138
123. M. Watanabe, T. Hayashi, T. Tsushima, S. Irie, T. Kaneshige, and H. Kumon Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection Int J Urol 12 2005 959 963
124. P. Emiliozzi, A. Corsetti, B. Tassi, G. Federico, M. Martini, and V. Pansadoro Best approach for prostate cancer detection: a prospective study on transperineal versus transrectal six-core prostate biopsy Urology 61 2003 961 966
125. A. Takenaka, R. Hara, and Y. Hyodo Transperineal extended biopsy improves the clinically significant prostate cancer detection rate: a comparative study of 6 and 12 biopsy cores Int J Urol 13 2006 10 14
126. S. Kawakami, F. Koga, Y. Fujii, K. Saito, S. Yamamoto, M. Tatokoro, J. Yonese, Y. Kageyama, I. Fukui, and K. Kihara History of malignancy is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram Int J Urol 15 12 2008 1055 1060
127. K. Kawamura, H. Suzuki, N. Kamiya, T. Imamoto, M. Yano, J. Miura, M. Shimbo, N. Suzuki, H. Nakatsu, and T. Ichikawa Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL Int J Urol 15 7 2008 598 603
128. C. Stephan, H. Cammann, M. Bender, K. Miller, M. Lein, K. Jung, and H.A. Meyer Internal validation of an artificial neural network for prostate biopsy outcome Int J Urol 2009